Schonfeld Strategic Advisors LLC Vbi Vaccines Inc Transaction History

Schonfeld Strategic Advisors LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$1.27 - $2.47 $90,170 - $175,370	-71,000 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$2.21 - $3.22 $56,355 - $82,110	-25,500 Reduced 26.42%	71,000 $166,000
Q3 2021 Nov 16, 2021	BUY	$2.8 - $3.72 $28,355 - $37,672	10,127 Added 11.72%	96,500 $300,000
Q2 2021 Aug 16, 2021	BUY	$2.61 - $4.17 $225,433 - $360,175	86,373 New	86,373 $290,000

688K

Ticker VBIV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 258,256,992
Market Cap $5.17M
Description
VBI Vaccines Inc., a biopharmaceutical company, develops and sells vaccines for the treatment of infectious diseases and immuno-oncology. The company offers Sci-B-Vac, a prophylactic hepatitis B (HBV) vaccine. It also engages in the development of VBI-2601 (BRII-179), an immunotherapeutic candidate for the treatment of chronic HBV infection. The...

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.